Showing results (31-40 of 414) with videos related to
Sort By:
Pageof 42
Deutsche Medizinische Wochenschrift (1946)|November 15, 2000
[Unclear lactate acidosis in a patient with heart failure under long-term diuretic therapy]T Duell, J Mittermüller, W HiddemannCell Biology International|November 1, 1994
Proliferation of human leukemic pre-B cells induced by human bone marrow stromal cells and murine fibroblastsC Buske, W Hiddemann, B WörmannDer Internist|January 9, 2014
[Chemotherapy of metastatic colorectal cancer]D P Modest, W Hiddemann, V HeinemannDeutsche Medizinische Wochenschrift (1946)|June 16, 2011
[Multiple Sister Mary Joseph's nodules in a patient with gastric cancer]L M Ehmann, M Fiegl, A WollenbergThe Breast Journal|February 15, 2002
Ulcerative breast cancer: case report and review of managementM Fiegl, H Kaufmann, G G StegerLaboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 2000
Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cellsC Binder, M Schulz, W Hiddemann, et al.Biotechniques|December 1, 1995
Short technical reports. Quantification of ribozyme-mediated RNA cleavage using silver-stained polyacrylamide gelsK Palfner, M Kneba, W Hiddemann, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1995
The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromesW Verbeek, K Vehmeyer, B Wörmann, et al.Journal of Internal Medicine. Supplement|January 1, 1997
Treatment of follicular follicle centre lymphomas: current status and future perspectivesW Hiddemann, M Unterhalt, C Buske, et al.Leukemia|March 23, 2007
The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factorsM Weisser, C Haferlach, W Hiddemann, et al.Pageof 42